Log In
person
Revance Therapeutics Inc
RVNC
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Product Segment |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
221.79M | 94.77% |
| Product Segment |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| Service Segment |
Medical Billing Software
These companies develop medical billing services, medical fee auditing, and claim processing and management.
|
12.25M | 5.23% |
| keyboard_arrow_down |
Product Segment
Branded Pharmaceuticals
|
221.79M | 94.77% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Product Segment
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Service Segment
Medical Billing Software
|
12.25M | 5.23% |
| keyboard_arrow_right |
These companies develop medical billing services, medical fee auditing, and claim processing and management.
|
||